Vinings Holdings Inc. Stock Other OTC
Equities
NDYN
US92744A1051
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 26.74M 36.56M |
---|---|---|---|---|---|
Net income 2022 | -37M -50.59M | Net income 2023 | -21M -28.71M | EV / Sales 2022 | - |
Net cash position 2022 | 2.08M 2.85M | Net cash position 2023 | 245K 335K | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.58
x | P/E ratio 2023 |
-0.95
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 67.46% |
Managers | Title | Age | Since |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 22-10-27 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 23-05-16 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 22-10-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 22-10-27 | |
Director/Board Member | 55 | 22-10-27 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 22-10-27 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |